SEC registrant · CIK 0001501989

CytomX Therapeutics, Inc. (CTMX)

CytomX Therapeutics, Inc. (CIK 0001501989, ticker CTMX, EIN 27-3521219) reported revenue of $76.2 million ($76,201,000) for FY2025 (2025-01-01 to 2025-12-31) and net income of -$17.37 million (-$17,368,000) for FY2025 (2025-01-01 to 2025-12-31), as filed in its 10-K filed 2026-03-16 (accession 0001193125-26-107146).

Figures are as filed with the SEC in XBRL, in whole US dollars unless stated, for the company's own fiscal years (fiscal year ends December 31).

Data as of Oct 21, 2026 (Olympus publication) · Markdown version

  • Values are as filed by the company in its 10-K and 10-Q XBRL data. When a later filing restates a value, the latest filed value is shown and the first reported value is noted.

Identifiers

As published in the company's EDGAR submissions record.

IdentifierValue
CIK0001501989
TickersCTMX (Nasdaq)
EIN27-3521219
SIC industry code2834 Pharmaceutical Preparations
State or country of incorporationDE
Fiscal year endDecember 31
Filer categoryAccelerated filer
Entity typeoperating
Olympus entity IDorg_42bn0ybhpc4gsc7tsx7pa0rdcx
  • The EIN is the one the filer gave to EDGAR. The SEC does not verify it; Olympus checks only that it has nine digits and a prefix the IRS assigns.

Latest annual financial metrics

The latest annual value of each standardised metric, with the filing it was taken from.

MetricValueFiscal periodPeriodFormFiledAccession numberXBRL concept
Revenue$76,201,000FY20252025-01-01 to 2025-12-3110-K2026-03-160001193125-26-107146Revenues
Net income-$17,368,000FY20252025-01-01 to 2025-12-3110-K2026-03-160001193125-26-107146NetIncomeLoss
Total assets$151,566,000FY2025as of 2025-12-3110-K2026-03-160001193125-26-107146Assets
Total liabilities$52,558,000FY2025as of 2025-12-3110-K2026-03-160001193125-26-107146Liabilities
Stockholders' equity$99,008,000FY2025as of 2025-12-3110-K2026-03-160001193125-26-107146StockholdersEquity
Operating cash flow-$75,587,000FY20252025-01-01 to 2025-12-3110-K2026-03-160001193125-26-107146NetCashProvidedByUsedInOperatingActivities
Diluted earnings per share-$1.16 per shareFY20172017-01-01 to 2017-12-3110-K2018-03-070001564590-18-004727EarningsPerShareBasicAndDiluted
Shares outstanding170,186,742 sharesFY2025as of 2025-12-3110-K2026-03-160001193125-26-107146EntityCommonStockSharesOutstanding
  • Accession numbers link to the filing's index on SEC EDGAR.

Revenue and net income history

Every annual revenue and net income value served for fiscal years 2016-2025, newest first, each with its filing.

MetricFiscal periodPeriodValueFormFiledAccession number
RevenueFY20252025-01-01 to 2025-12-31$76,201,00010-K2026-03-160001193125-26-107146
RevenueFY20242024-01-01 to 2024-12-31$138,103,00010-K2026-03-160001193125-26-107146
RevenueFY20232023-01-01 to 2023-12-31$101,214,00010-K2025-03-060000950170-25-034575
RevenueFY20222022-01-01 to 2022-12-31$53,163,00010-K2024-03-110000950170-24-029191
RevenueFY20212021-01-01 to 2021-12-31$37,312,00010-K2023-03-270000950170-23-009991
RevenueFY20202020-01-01 to 2020-12-31$68,427,00010-K/A2023-03-270000950170-23-009984
RevenueFY20192019-01-01 to 2019-12-31$26,902,00010-K/A2023-03-270000950170-23-009984
RevenueFY20182018-01-01 to 2018-12-31$59,502,00010-K2021-02-240001564590-21-008081
RevenueFY20172017-01-01 to 2017-12-31$71,623,00010-K2020-02-270001564590-20-007395
RevenueFY20162016-01-01 to 2016-12-31$15,043,00010-K2019-02-270001564590-19-004890
Net incomeFY20252025-01-01 to 2025-12-31-$17,368,00010-K2026-03-160001193125-26-107146
Net incomeFY20242024-01-01 to 2024-12-31$31,869,00010-K2026-03-160001193125-26-107146
Net incomeFY20232023-01-01 to 2023-12-31-$569,00010-K2025-03-060000950170-25-034575
Net incomeFY20222022-01-01 to 2022-12-31-$99,317,00010-K2024-03-110000950170-24-029191
Net incomeFY20212021-01-01 to 2021-12-31-$115,870,00010-K2023-03-270000950170-23-009991
Net incomeFY20202020-01-01 to 2020-12-31-$64,820,00010-K/A2023-03-270000950170-23-009984
Net incomeFY20192019-01-01 to 2019-12-31-$132,825,00010-K/A2023-03-270000950170-23-009984
Net incomeFY20182018-01-01 to 2018-12-31-$84,604,00010-K2021-02-240001564590-21-008081
Net incomeFY20172017-01-01 to 2017-12-31-$43,099,00010-K2020-02-270001564590-20-007395
Net incomeFY20162016-01-01 to 2016-12-31-$58,900,00010-K2019-02-270001564590-19-004890
  • Revenue for FY2021 was restated: first reported as $69,573,000 (accession 0000950170-22-002519, filed 2022-03-01).
  • Revenue for FY2020 was restated: first reported as $100,362,000 (accession 0001564590-21-008081, filed 2021-02-24).
  • Revenue for FY2019 was restated: first reported as $57,489,000 (accession 0001564590-20-007395, filed 2020-02-27).
  • Net income for FY2021 was restated: first reported as -$83,609,000 (accession 0000950170-22-002519, filed 2022-03-01).
  • Net income for FY2020 was restated: first reported as -$32,885,000 (accession 0001564590-21-008081, filed 2021-02-24).
  • Net income for FY2019 was restated: first reported as -$102,238,000 (accession 0001564590-20-007395, filed 2020-02-27).

Recent 10-K and 10-Q filings

The 12 most recent 10-K, 10-Q and amendment filings in EDGAR, newest first.

FormFiledPeriod of reportAccession numberDocument
10-Q2026-08-062026-06-300001193125-26-337950ctmx-20260630.htm
10-Q2026-05-072026-03-310001193125-26-211868ctmx-20260331.htm
10-K2026-03-162025-12-310001193125-26-107146ctmx-20251231.htm
10-Q2025-11-062025-09-300001193125-25-269477ctmx-20250930.htm
10-Q2025-08-072025-06-300000950170-25-104991ctmx-20250630.htm
10-Q2025-05-122025-03-310000950170-25-068511ctmx-20250331.htm
10-K2025-03-062024-12-310000950170-25-034575ctmx-20241231.htm
10-Q2024-11-072024-09-300000950170-24-123249ctmx-20240930.htm
10-Q2024-08-082024-06-300000950170-24-093865ctmx-20240630.htm
10-Q2024-05-082024-03-310000950170-24-055588ctmx-20240331.htm
10-K2024-03-112023-12-310000950170-24-029191ctmx-20231231.htm
10-Q2023-11-072023-09-300000950170-23-060201ctmx-20230930.htm

Identifier registry

The company's identifiers in the Olympus identifier registry, each with how it was linked and its source.

SchemeValueHow linkedSourcePublished
SEC Central Index Key (CIK) · OLY-US-SEC-CIK0001501989published by the sourcedata.sec.gov/submissions/CIK0001501989.json2026-10-21
Employer Identification Number (EIN) · US-EIN27-3521219published by the sourceaskebsa.dol.gov/FOIA%20Files/2024/Latest/F_5500_2024_Latest.zip2026-10-22
Employer Identification Number (EIN) · US-EIN27-3521219published by the sourcedata.sec.gov/submissions/CIK0001501989.json2026-10-21

Same entity in other Olympus APIs

Records other Olympus APIs serve for this entity, linked through a published identifier (never matched on name).

APIRecordAPI pathLinked through
US Employee Benefits & Form 5500 APIsponsor/v1/form-5500/sponsors/273521219US-EIN 273521219

Sources

  • EDGAR submissions (nightly bulk archive) (company profile and filings) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:f7d2a4f18cb91aae, source date 2026-10-20. https://data.sec.gov/submissions/CIK0001501989.json
  • EDGAR XBRL company facts (nightly bulk archive) (financial metrics) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:01e4045aa34d7224, source date 2026-10-20. https://data.sec.gov/api/xbrl/companyfacts/CIK0001501989.json
  • Published by Olympus on Oct 21, 2026.
  • Source data: U.S. Securities and Exchange Commission (EDGAR). Values are as filed by the registrant; Olympus does not audit or adjust them.
  • Olympus is not affiliated with or endorsed by the U.S. Securities and Exchange Commission.

Get this data from the API

The same figures, with provenance on every value, from the API (free API key, reference) or from an AI agent through the Olympus MCP server.

curl
curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001501989" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001501989/financials" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001501989/filings?limit=12" -H "X-API-Key: $OLYMPUS_API_KEY"
MCP tool call
get_sec_company_financials {"cik":"1501989"}

On SEC EDGAR

About this data